Here's Why Fate Therapeutics Rose as Much as 18% Today [The Motley Fool]
JUNO THERAPEUTICS (JUNO)
Last juno therapeutics earnings: 11/1 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.junotherapeutics.com/investor-relations
Company Research
Source: The Motley Fool
Make that two consecutive days of riding the momentum from the Juno Therapeutics acquisition. Maxx Chatsko ( TMFBlacknGold ) Jan 23, 2018 at 12:09PM What happened When Celgene announced it was acquiring Juno Therapeutics for $9 billion yesterday , it sent a wave through the market. Shares of many biopharma companies developing immunotherapies caught it, rode it, and then hopped off when the market closed yesterday. Fate Therapeutics ( NASDAQ:FATE ) didn't get the memo. Shares of the small-cap biopharma rose 18% today -- following yesterday's 13.7% trek higher -- as investors kept the momentum going. While Fate Therapeutics is actually partnered with Juno Therapeutics on an early-stage program, the recent share appreciation seems to be a nod to the company's broad immunotherapy potential. As of 11:35 a.m. EST, the stock had settled to a
Show less
Read more
Impact Snapshot
Event Time:
JUNO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JUNO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JUNO alerts
High impacting JUNO THERAPEUTICS news events
Weekly update
A roundup of the hottest topics